1,​5,​6,​7,​8,​9-​Hexahydro-​5,​9-​methanoimidazo[4,​5-​h]​[3]​benzazepine hydrochloride
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

230615-10-81,​5,​6,​7,​8,​9-​Hexahydro-​5,​9-​methanoimidazo[4,​5-​h]​[3]​benzazepine hydrochloride

● Under Development

Catalogue No.:VE0010394
CAS No.:230615-10-8
Mol. Formula:C12H13N3•(HCl)
Mol. Weight:235.71 g/mol

Additional information on CAS 230615-10-8

Parent drug

Varenicline

IUPAC Name

1,​5,​6,​7,​8,​9-​Hexahydro-​5,​9-​methanoimidazo[4,​5-​h]​[3]​benzazepine hydrochloride

Synonyms

1,5,6,7,8,9-Hexahydro-5,9-methanoimidazo[4′,5′:4,5]benzo[1,2-d]azepine hydrocloride ; Varenicline Impurity 3 (Hydrochloride) ; 1,5,6,7,8,9-Hexahydro-5,9-methanoimidazo[4,5-h][3]benzazepine hydrochloride;

Description

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url